ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thermo Fisher Scientific and researchers in Tokyo will open a center focused on biomarker discovery, disease mechanisms, and drug monitoring. Thermo Fisher’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center, in Cambridge, Mass., is collaborating with Tokyo Medical University Hospital professors Toshihide Nishimura and Gyorgy Marko-Varga. Marko-Varga is also a professor at Lund University, in Sweden, and a scientist at AstraZeneca. The Tokyo Biomarker Research Center will be modeled after the BRIMS Center.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter